Research Data Stack Suggestions GHRP-6 is often combined in research with: GHRP-6 + CJC-1295 Synergistic stimulation of GH pulsatility through combined GHRH and ghrelin receptor activation
Trial design: 2,339 participants Adults with obesity or overweight + at least one weight-related complication Participants did NOT have diabetes Randomized to placebo or retatrutide 4 mg, 9 mg or 12 mg 80-week double-blind trial Pre-specified extension to 104 weeks in participants with BMI 35 Weight loss results at 80 weeks: 4 mg: -19.0% (~47 lbs / 21.4 kg) 9 mg: -25.9% (~64 lbs / 29.2 kg) 12 mg: -28.3% (~70 lbs / 31.9 kg) That degree of weight loss approaches levels traditionally associated with bariatric surgery
Grounded in science and compassion, Helen helps readers build habits that support lasting change beyond the medication itself
NAD+ ensures those cells have the energy substrate they need
The NEJM phase 2 obesity trial reports published retatrutide study design, dose groups, and safety findings
Traditional protein powders and branched-chain amino acid (BCAA) products typically emphasize macronutrient delivery or single-category amino supplementation